At Seqirus, we are driven by just one goal - to lessen the severity and impact of influenza, which can reach epidemic or even pandemic proportions with life-threatening consequences. Every year our influenza vaccines help protect millions of people. We find solutions to big, complex, challenging problems, and we see the results in the world around us. Then we do it all over again the following year.
Seqirus is one of the world’s largest influenza vaccine companies. We were created when our parent company, CSL Limited, acquired the Novartis influenza vaccine business and combined it with vaccine subsidiary, bioCSL.
The information on this website is intended for health care professionals only. Product information is for educational purposes only, and not all products or indications are licensed in every country. Product availability are subject to individual country license, rules, and regulations. The information on this website may not be reflecting the most updated information. Please contact directly for the most updated product information and availability.